Page 168 - Read Online

Tian et al. EMT drives anti-estrogen resistance in breast cancer

Institutes of Health to W.P.S. (CA129359, CA177069, effect of COX-2 on TGF-b signaling during mammary tumorigenesis.
and CA194518). FASEB J 2010;24:1105-16.
18. Wrana JL, Attisano L, Carcamo J, Zentella A, Doody J, Laiho M,
Conflicts of interest Wang XF, Massague J. TGFb signals through a heteromeric protein
kinase receptor complex. Cell 1992;71:1003-14.
There are no conflicts of interest. 19. Hall JM, McDonnell DP. The estrogen receptor b-isoform (ERb) of the
human estrogen receptor modulates ERa transcriptional activity and is
Patient consent a key regulator of the cellular response to estrogens and antiestrogens.
Endocrinology 1999;140:5566-78.
Not applicable. 20. Veeman MT, Slusarski DC, Kaykas A, Louie SH, Moon RT. Zebrafish
prickle, a modulator of noncanonical Wnt/Fz signaling, regulates
Ethics approval gastrulation movements. Curr Biol 2003;13:680-5.
The study was approved by Institutional Scientific and 21. Schiemann WP, Pfeifer WM, Levi E, Kadin ME, Lodish HF. A
Ethical Committees. deletion in the gene for transforming growth factor b type I receptor
abolishes growth regulation by transforming growth factor b in a
cutaneous T-cell lymphoma. Blood 1999;94:2854-61.
REFERENCES 22. Chaffer CL, San Juan BP, Lim E, Weinberg RA. EMT, cell plasticity
and metastasis. Cancer Metastasis Rev 2016;35:645-54.
1. Massague J. TGFb signalling in context. Nat Rev Mol Cell Biol 23. Wendt MK, Tian M, Schiemann WP. Deconstructing the mechanisms
2012;13:616-30. and consequences of TGF-b-induced EMT during cancer progression.
2. Tian M, Neil JR, Schiemann WP. Transforming growth factor-b and Cell Tissue Res 2012;347:85-101.
the hallmarks of cancer. Cell Signal 2011;23:951-62. 24. Morrison CD, Parvani JG, Schiemann WP. The relevance of the
3. Tian M, Schiemann WP. The TGF-b paradox in human cancer: an TGF-b paradox to EMT-MET Programs. Cancer Lett 2013;341:30-40.
update. Future Oncol 2009;5:259-71. 25. Taylor MA, Amin J, Kirschmann DA, Schiemann WP. Lysyl
4. Parvani JG, Taylor MA, Schiemann WP. Noncanonical TGF-b oxidase contributes to mechanotransduction-mediated regulation
signaling during mammary tumorigenesis. J Mammary Gland Biol of transforming growth factor-b signaling in breast cancer cells.
Neoplasia 2011;16:127-46. Neoplasia 2011;13:406-18.
5. Taylor MA, Parvani JG, Schiemann WP. The pathophysiology of 26. Wei SC, Fattet L, Tsai JH, Guo Y, Pai VH, Majeski HE, Chen AC, Sah
epithelial-mesenchymal transition induced by transforming growth RL, Taylor SS, Engler AJ, Yang J. Matrix stiffness drives epithelial-
factor-b in normal and malignant mammary epithelial cells. J mesenchymal transition and tumour metastasis through a TWIST1-
Mammary Gland Biol Neoplasia 2010;15:169-90. G3BP2 mechanotransduction pathway. Nat Cell Biol 2015;17:678-88.
6. Arendt LM, Kuperwasser C. Form and function: how estrogen and 27. Gilbert PM, Weaver VM. Cellular adaptation to biomechanical stress
progesterone regulate the mammary epithelial hierarchy. J Mammary across length scales in tissue homeostasis and disease. Semin Cell Dev
Gland Biol Neoplasia 2015;20:9-25. Biol 2017;67:141-152.
7. Finlay-Schultz J, Sartorius CA. Steroid hormones, steroid receptors, 28. Band AM, Laiho M. Crosstalk of TGF-b and estrogen receptor
and breast cancer stem cells. J Mammary Gland Biol Neoplasia signaling in breast cancer. J Mammary Gland Biol Neoplasia
2015;20:39-50. 2011;16:109-15.
8. Ali S, Coombes RC. Estrogen receptor a in human breast cancer: 29. Song RX, Zhang Z, Santen RJ. Estrogen rapid action via protein
occurrence and significance. J Mammary Gland Biol Neoplasia complex formation involving ERa and Src. Trends Endocrinol Metab
2000;5:271-81. 2005;16:347-53.
9. Ali S, Coombes RC. Endocrine-responsive breast cancer and strategies 30. Xie L, Law BK, Chytil AM, Brown KA, Aakre ME, Moses HL.
for combating resistance. Nat Rev Cancer 2002;2:101-12. Activation of the Erk pathway is required for TGF-b1-induced EMT
10. Osborne CK, Fuqua SA. Mechanisms of tamoxifen resistance. Breast in vitro. Neoplasia 2004;6:603-10.
Cancer Res Treat 1994;32:49-55. 31. Santen RJ, Fan P, Zhang Z, Bao Y, Song RX, Yue W. Estrogen
11. Song RX, Barnes CJ, Zhang Z, Bao Y, Kumar R, Santen RJ. The signals via an extra-nuclear pathway involving IGF-1R and EGFR
role of Shc and insulin-like growth factor 1 receptor in mediating the in tamoxifen-sensitive and -resistant breast cancer cells. Steroids
translocation of estrogen receptor a to the plasma membrane. Proc 2009;74:586-94.
Natl Acad Sci U S A 2004;101:2076-81. 32. Fan P, Wang J, Santen RJ, Yue W. Long-term treatment with tamoxifen
12. Song RX, Chen Y, Zhang Z, Bao Y, Yue W, Wang JP, Fan P, Santen RJ. facilitates translocation of estrogen receptor a out of the nucleus and
Estrogen utilization of IGF-1-R and EGF-R to signal in breast cancer enhances its interaction with EGFR in MCF-7 breast cancer cells.
cells. J Steroid Biochem Mol Biol 2010;118:219-30. Cancer Res 2007;67:1352-60.
13. Song RX, Zhang Z, Chen Y, Bao Y, Santen RJ. Estrogen signaling 33. Thomson S, Petti F, Sujka-Kwok I, Mercado P, Bean J, Monaghan
via a linear pathway involving insulin-like growth factor I receptor, M, Seymour SL, Argast GM, Epstein DM, Haley JD. A systems
matrix metalloproteinases, and epidermal growth factor receptor to view of epithelial-mesenchymal transition signaling states. Clin Exp
activate mitogen-activated protein kinase in MCF-7 breast cancer Metastasis 2011;28:137-55.
cells. Endocrinology 2007;148:4091-101. 34. Hiscox S, Jiang WG, Obermeier K, Taylor K, Morgan L, Burmi
14. Kumar R, Wang RA, Mazumdar A, Talukder AH, Mandal M, Yang R, Barrow D, Nicholson RI. Tamoxifen resistance in MCF7 cells
Z, Bagheri-Yarmand R, Sahin A, Hortobagyi G, Adam L, Barnes promotes EMT-like behaviour and involves modulation of b-catenin
CJ, Vadlamudi RK. A naturally occurring MTA1 variant sequesters phosphorylation. Int J Cancer 2006;118:290-301.
oestrogen receptor-a in the cytoplasm. Nature 2002;418:654-7. 35. Arumugam T, Ramachandran V, Fournier KF, Wang H, Marquis L,
15. Parvani JG, Davuluri G, Wendt MK, Espinosa C, Tian M, Danielpour Abbruzzese JL, Gallick GE, Logsdon CD, McConkey DJ, Choi W.
D, Sossey-Alaoui K, Schiemann WP. Deptor enhances triple-negative Epithelial to mesenchymal transition contributes to drug resistance in
breast cancer metastasis and chemoresistance through coupling to pancreatic cancer. Cancer Res 2009;69:5820-8.
survivin expression. Neoplasia 2015;17:317-28. 36. McConkey DJ, Choi W, Marquis L, Martin F, Williams MB, Shah
16. Tian M, Schiemann WP. Preclinical efficacy of cystatin C to target the J, Svatek R, Das A, Adam L, Kamat A, Siefker-Radtke A, Dinney
oncogenic activity of transforming growth factor b in breast cancer. C. Role of epithelial-to-mesenchymal transition (EMT) in drug
Transl Oncol 2009;2:174-83. sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev
17. Tian M, Schiemann WP. PGE2 receptor EP2 mediates the antagonistic 2009;28:335-44.
160 Journal of Cancer Metastasis and Treatment ¦ Volume 3 ¦ August 21, 2017